Showing results (1641-1650 of 1,751) with videos related to

Sort By:
Pageof 176
Hemasphere|September 25, 2025
Elevated circulating tumor cells reflect high proliferation and genomic complexity in multiple myelomaJuan-Jose Garces, Benjamin Diamond, Tereza Sevcikova, et al.
Leukemia|April 23, 2010
Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and managementR A Kyle, B G M Durie, S V Rajkumar, et al.
Bipolar Disorders|June 26, 2021
Consensus on nomenclature for clinical staging models in bipolar disorder: A narrative review from the International Society for Bipolar Disorders (ISBD) Staging Task ForceRalph Kupka, Anne Duffy, Jan Scott, et al.
Med (New York, N.Y.)|August 16, 2024
Pembrolizumab plus chemotherapy in frontline treatment of advanced ovarian cancer: Clinical and translational results from a phase 2 trialJeffrey A How, Minghao Dang, Sanghoon Lee, et al.
Acta Psychiatrica Scandinavica|July 15, 2022
Demographic and clinical characteristics of lithium-treated older adults with bipolar disorderOrestes V Forlenza, Tomas Hajek, Osvaldo P Almeida, et al.
Global Change Biology|September 10, 2025
Multiyear Drought Strengthens Positive and Negative Functional Diversity Effects on Tree Growth ResponseHernán Serrano-León, Haben Blondeel, Paula Glenz, et al.
Preventive Medicine Reports|March 27, 2024
Personality and the use of cancer screenings - Results of the German National CohortAndré Hajek, Heiko Becher, Hermann Brenner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 25, 2022
Single-Nucleotide Variants and Epimutations Induce Proteasome Inhibitor Resistance in Multiple MyelomaLarissa Haertle, Santiago Barrio, Umair Munawar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 16, 2012
Superiority of the triple combination of bortezomib-thalidomide-dexamethasone over the dual combination of thalidomide-dexamethasone in patients with multiple myeloma progressing or relapsing after autologous transplantation: the MMVAR/IFM 2005-04 Randomized Phase III Trial from the Chronic Leukemia Working Party of the European Group for Blood and Marrow TransplantationLaurent Garderet, Simona Iacobelli, Philippe Moreau, et al.
The New Phytologist|June 10, 2024
Mycorrhizal associations modify tree diversity-productivity relationships across experimental tree plantationsShan Luo, Bernhard Schmid, Andy Hector, et al.
Pageof 176